IMTX
IMTX
NASDAQ · Biotechnology

Immatics Nv

$9.78
+0.26 (+2.73%)
As of Jun 21, 10:09 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +689.9% upside
Low Target $52.47
Average Target $77.25
High Target $103.74
Current Price $9.78
Current
$9.78
Target
$77.25
$52.47 $77.25 avg $103.74
Scenario Analysis
Bear Case
$52.47
436.5%
Low target
Base Case
$77.25
+689.9%
Avg target
Bull Case
$103.74
+960.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$12.41
-21.2% from high
52-Week Low
$5.05
+93.7% from low
Target vs 52W High
$77.25
+522.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%